Purimed Co., Ltd. Report issue

For profit Phase 2
Founded: Seoul Korea, Republic of (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2012
NCT01715350
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now